Patents by Inventor Renato Mastrangeli

Renato Mastrangeli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mutants of the LAG-3 proteins and nucleotides encoding LAG-3 mutants
    Patent number: 6482925
    Abstract: The invention concerns a purified polypeptide corresponding to a mutated form of the soluble LAG-3 protein or of one of its fragments comprising the extra-cellular domain D1 and D2.
    Type: Grant
    Filed: January 6, 2000
    Date of Patent: November 19, 2002
    Assignee: Applied Research Systems ARS Holding N.V.
    Inventors: Nabil El Tayar, Bertrand Huard, Renato Mastrangeli, Frederic Triebel
  • Component B as cicatrizant
    Patent number: 5998364
    Abstract: The present invention relates to the use of Component B as cicatrizant, in particular in the treatment of wounds, ulcers and other traumatic lesions to any of the tissues in the body.
    Type: Grant
    Filed: January 27, 1999
    Date of Patent: December 7, 1999
    Assignee: Applied Research Systems Ars Holding N.V.
    Inventors: Francesco Borrelli, Silvia Donini, Fabrizio Martelli, Renato Mastrangeli